key: cord-0267670-0t152s69
authors: Krasemann, S.; Dittmayer, C.; v. Stillfried, S.; Meinhardt, J.; Heinrich, F.; Hartmann, K.; Pfefferle, S.; Thies, E.; v. Manitius, R.; Aschman, T.; Radke, J.; Osterloh, A.; Schmid, S.; Buhl, E. M.; Ihlow, J.; Elezkurtaj, S.; Horst, D.; Hocke, A. C.; Timm, S.; Bachmann, S.; Corman, V.; Goebel, H.-H.; Matschke, J.; Stanelle-Bertram, S.; Gabriel, G.; Seilhean, D.; Adle-Biassette, H.; Ondruschka, B.; Ochs, M.; Stenzel, W.; Heppner, F.; Boor, P.; Radbruch, H.; Laue, M.; Glatzel, M.
title: Assessing and improving the validity of COVID-19 autopsy studies - a multi center approach to establish essential standards for immunohistochemical and ultrastructural analyses
date: 2022-01-13
journal: nan
DOI: 10.1101/2022.01.13.22269205
sha: 015af01291a35531d442a4d1f3ef9d479dd0eb47
doc_id: 267670
cord_uid: 0t152s69

Background Autopsy studies have provided valuable insights into the pathophysiology of COVID-19. Controversies remain whether the clinical presentation is due to direct organ damage by SARS-CoV-2 or secondary effects, e.g. by an overshooting immune response. SARS-CoV-2 detection in tissues by RT-qPCR and immunohistochemistry (IHC) or electron microscopy (EM) can help answer these questions, but a comprehensive evaluation of these applications is missing. Methods We assessed publications using IHC and EM for SARS-CoV-2 detection in autopsy tissues. We systematically evaluated commercially available antibodies against the SARS-CoV-2 spike protein and nucleocapsid, dsRNA, and non-structural protein Nsp3 in cultured cell lines and COVID-19 autopsy tissues. In a multicenter study, we evaluated specificity, reproducibility, and inter-observer variability of SARS-CoV-2 nucleocapsid staining. We correlated RT-qPCR viral tissue loads with semiquantitative IHC scoring. We used qualitative and quantitative EM analyses to refine criteria for ultrastructural identification of SARS-CoV-2. Findings Publications show high variability in the detection and interpretation of SARS-CoV-2 abundance in autopsy tissues by IHC or EM. In our study, we show that IHC using antibodies against SARS-CoV-2 nucleocapsid yields the highest sensitivity and specificity. We found a positive correlation between presence of viral proteins by IHC and RT-qPCR-determined SARS-CoV-2 viral RNA load (r=-0.83, p-value <0.0001). For EM, we refined criteria for virus identification and also provide recommendations for optimized sampling and analysis. 116 of 122 publications misinterpret cellular structures as virus using EM or show only insufficient data. We provide publicly accessible digitized EM and IHC sections as a reference and for training purposes. Interpretation Since detection of SARS-CoV-2 in human autopsy tissues by IHC and EM is difficult and frequently incorrect, we propose criteria for a re-evaluation of available data and guidance for further investigations of direct organ effects by SARS-CoV-2.

In clinical routine, quantitative reverse transcriptase (RT)-qPCR and rapid antigen detection tests from nasopharyngeal swabs are robust, standardized, and validated tools for screening or diagnosing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. In contrast, in situ SARS-CoV-2 detection methods such as immunohistochemistry (IHC) and electron microscopy (EM) in patient tissues are much less investigated and validated, yet autopsy studies use these methods to investigate mechanisms of organ damage and organ tropism of SARS-CoV-2 1-6 .

Detection of pathogen-specific antigens by immunohistochemical staining is a potent diagnostic tool allowing for spatial correlation of pathological changes with presence of the pathogen. At the beginning of the COVID-19 pandemic, positive controls for this newly emerging disease were not available, neither for diagnostic nor for research applications. The urgent need to publish data on the distribution of SARS-CoV-2 in tissues of deceased patients with mentioned technical limitations led to inconsistencies in interpretation of SARS-CoV-2 localization and distribution by IHC and EM [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] .

Diagnostic EM is the only technique to directly visualize and detect intact SARS-CoV-2 particles 11, 12 . It thereby validates other in situ viral-detection techniques, detecting viral proteins or RNA, and enables cellular and subcellular localization of virus particles 11 . EM of virus molecules or particles in model systems expanded our understanding of SARS-CoV-2 structural and cellular biology, yet did not provide information on the distribution of the virus in human tissues [13] [14] [15] [16] [17] .

Due to complex sample processing procedures in electron microscopy and challenges in recording and interpretation of micrographs, misinterpretation of structures as SARS-CoV-2 particles in patient tissues occurred [18] [19] [20] . In autopsy tissues, virus structures have to be distinguished from other structures of cells.

For this task, sufficient structural preservation of the tissue and a suitable sampling strategy to detect infected cells are needed 8, 18, 21 . Recommendations for identifying SARS-CoV-2 particles by EM are mainly based on virus particles in cell cultures 22, 23 which only partially reflect the situation in autopsy tissues. In fact, misinterpretations or findings with insufficient evidence have still been published 3, 24 .

Here we collated available data on in situ detection of SARS-CoV-2 in human tissue samples focussing on immunohistochemical detection of SARS-CoV-2 proteins and EM detection of intact SARS-CoV-2 particles. Furthermore, we determined optimally suited SARS-CoV-2 antibodies and evaluated their sensitivity and specificity in a multicenter approach, which allowed a correlation between the viral load detected by RT-qPCR and by IHC. Additionally, we refined criteria for identifying SARS-CoV-2 by IHC and EM and provide a publicly accessible repository of entirely digitized light-and electron microscopical

sections showing examples and pitfalls for in situ detection of SARS-CoV-2.

We generated paraffin cell blocks from SARS-CoV-2-infected and un-infected Vero cells (see Supplementary Methods for details) and processed these as if they were autopsy samples regarding fixation time in 10% formalin and paraffin embedding. Furthermore, SARS-CoV-2-infected and un-infected Vero cells were grown on coverslips and fixed in 4% formaldehyde solution. Autopsy samples from lungs and respiratory mucosa from COVID-19 patients and controls were formalin-fixed and paraffin-embedded (FFPE) using standard laboratory procedures from three study centers. Beside hematoxylin and eosin staining, immunohistochemistry with several antibodies against different SARS-CoV-2 proteins (see Supplementary Table 2 ) were performed using a Ventana Benchmark XT autostainer at two centers. For the multicenter study evaluating IHC to SARS-CoV-2 nucleocapsid, we used antibody N#9. Staining specificity and intensity were evaluated by eight independent pathologists/neuropathologists at four different centers (Pathology Aachen, Neuropathology Berlin, Neuropathology Hamburg, Pathology Paris). Observers received instructions and a set of stained slides and were then asked to categorize each slide in a blinded fashion, using a published four-tiered semiquantitative approach (none (0), slight (+), moderate (++), and severe (+++) 25 (Figure 3 ). Training slides were annotated, uploaded, and are publicly available using OMERO 26 . Correlation of RT-qPCR (Pearson r) values and scoring was analyzed using Graphpad Prism (GraphPad Software Version 8, La Jolla, USA) with 34 pairs. Every case was rated by seven investigators. Cases with ≥70% agreement amongst raters (at least 5 from 7 raters) were classified as positive ("+" or more) or negative, respectively. Cases with unclear classification into positive or negative due to inconsistent ratings (less than 60% agreement) were defined as non-classifiable (n=2; one control / one COVID-19). Sensitivity was calculated as Sensitivity = True positive/True positive + False negative. Specificity was calculated as Specificity = True negative/True negative + False positive (see Supplementary Table 5 ). Table 6) .

For qualitative and quantitative analyses of infected cells and viral particles, autopsy lung tissue (Supplementary Table 6 , case 1) and FFPE re-embedded olfactory mucosa (case 2) with a high viral RNA load, as determined by RT-qPCR, and successful detection of particles by EM were used.

Four large sections prepared from different resin blocks of two autopsy lung samples (case 1) and two sections prepared from different resin blocks from SARS-CoV-2-infected Vero cells were completely digitized at 3-4 nm pixel size as recently described 27 to screen for SARS-CoV-2 particles (Supplementary Material). The screening datasets were processed via Fiji software/TrakEM2 plugin 28 and nip2 software to generate high-resolution tif files 27 for in-depth analysis using QuPath software 0.2.0. 29 . In the autopsy lung, in total, 15 infected cells were detected, all located within two of the four digitized sections (dataset 1 and 2 on www.nanotomy.org). Subsequently, the infected cells were annotated and digitized at 1 nm pixel size for quantitative analysis in QuPath. Selected regions showing extracellular particles and non-infected cells were also digitized. To assess the heterogeneity of coronavirus (CoV) particles and their distribution in infected cells, four different categories of particles were specified; dark type 1 particles, bright type 2 particles, deformed type 3 particles, and extracellular type 4 particles ( Figure 5D -S). These types were counted manually in QuPath. Also, total area (in µm 2 ) of infected cells, area of the nucleus, and area of luminal structures were measured with the polygon All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 13, 2022. ; https://doi.org/10.1101/2022.01.13.22269205 doi: medRxiv preprint tool to determine the density of intracellular CoV particles per µm 2 cytoplasmic area. Intracellular CoV particles were analysed for particle diameter (largest diameter without spikes), ribonucleoprotein (RNP) diameter (smallest diameter, granular or elongated profiles), and diameter of tubular structures (cells 2 and 15). Measurements were performed with the line annotation tool, analysis was done in Excel (Office Home and Student 2019; Microsoft Corporation, Redmond, USA). Average, standard deviation, minimal and maximal values were determined for CoV diameter, RNP diameter, and tubular structure diameter.

No measurements were excluded during data processing.

In FFPE re-embedded olfactory mucosa (case 2), we restricted quantitative analysis to measurement of virus particle diameter due to limited preservation. The maximal diameter of intracellular particles (without spikes), based on TEM images, was measured using Fiji 30 and the "straight line" tool.

We roughly compared viral RNA load measured by RT-qPCR with virus particle number per section and cell to estimate the likelihood of finding CoV particles via thin section EM (Supplementary Methods).

We defined specific search strategies to find scientific publications using immunohistochemical datasets from autopsy studies with antibodies to SARS-CoV-2 proteins. Additionally, we searched for all scientific publications claiming ultrastructural proof of SARS-CoV-2 particles in infected human tissues (see

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 13, 2022. ; https://doi.org/10.1101/2022.01.13.22269205 doi: medRxiv preprint

We curated papers with immunohistochemical datasets for inclusion into our overview table (Supplementary Table 1 ). Detection of SARS-CoV-2 spike and nucleocapsid by immunohistochemistry in autopsy tissues showed differences regarding virus protein amounts and interpretation of data.

Furthermore, results of adequate positive and negative controls were rarely reported (Supplementary Table 1 ).

Of the 13 commercially available anti-SARS-CoV-2 protein antibodies that were evaluated in this study, three target the spike protein, two target non-structural protein 3 (Nsp3), seven target the nucleocapsid protein, and one targets double-strand RNA (dsRNA) (Supplementary Table 2 ). To further investigate the specificity of antibodies that have been widely used before in research, but did not perform well in our FFPE cell-based evaluation, we infected Vero cells with SARS-CoV-2, fixed them in formalin, and stained them without prior embedding into paraffin. To determine viral protein distribution, cells were double-stained with one of the specific nucleocapsid antibodies (#7 or #9) and one of the antibodies in question against spike #3, Nsp3 #5, dsRNA #6, and nucleocapsid #12, respectively (Supplementary Figure 2) . Un-infected cells served as control. While antibodies #5, #6, and #12 produced specific staining, antibody #3 did not produce a detectable signal again (Supplementary Figure 2 ). Since antibodies #4 and #13 did not produce specific signals in FFPE cell blocks or fixed cells, they were not further considered.

To assess the performance of anti-SARS-CoV-2 antibodies in COVID-19 autopsy tissues, we tested nine of the antibodies on FFPE autopsy tissues from COVID-19 patients and controls. We chose lung and respiratory mucosa as these tissue compartments harbor high SARS-CoV-2 viral loads and we stained consecutive sections with our panel of antibodies ( Figure 1; Supplementary Figure 3 ). Again, two out of three anti-spike antibodies produced specific staining, while one gave no signal (#3). Of the six different nucleocapsid antibodies, five antibodies showed specific and robust staining. However, the background staining in COVID-19-positive tissues was higher in the polyclonal (#7) and one monoclonal (#11) compared to the other monoclonal antibodies tested in our study. Background staining caused by presence of SARS-CoV-2 proteins in cellular debris or tissue artifacts was higher in lung tissue when All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 13, 2022. Our recommendations for the usage of antibodies for the detection of anti-SARS-CoV-2 proteins in human autopsy tissues are summarized in Table 1 and Supplementary Table 3 .

We selected one monoclonal antibody against nucleocapsid (#9) which showed a very reliable signal in cells and human autopsy tissues with minimal background staining ( Figure 1A Table 5 ). Extensive tissue damage seen in COVID-19 lungs, where pre-necrotic epithelial cells and hyaline membranes obscured interpretation of signals. The All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 13, 2022. ; https://doi.org/10.1101/2022.01.13.22269205 doi: medRxiv preprint specificity for antibody #9 was high at 0.98 (40 True negative/ 40 True negative + 1 False positive; see   Supplementary Table 5) . A correlation between RT-qPCR-defined SARS-CoV-2 viral loads and the presence of immunohistochemically detected SARS-CoV-2 nucleocapsid protein was seen in tissues with high SARS-CoV-2 viral loads ( Figure 3 ). COVID-19 tissues with low viral RNA loads were often rated false negative (n=7 with a mean ct value of 28.7) which could be true negative as, in these cases with only a low RNA signal there is probably no SARS-CoV-2 protein, however, in our calculations these figure as false negative. Only two cases out of 71 were not classifiable with an interrater agreement of less than 60%. The overall interrater reliability documented as interrater agreement frequency was 62% and reliability increased up to 83% if only trained raters with experience in SARS-CoV-2 IHC were included (Supplementary Table 5 ) 31 . The majority of cases with interrater discrepancy (all raters) were controls (n=14) compared to COVID-19 (n=9), and almost always these cases were rated with single positive cells (Controls and COVID-19 cases). In contrast, COVID-19 cases with a high viral RNA load and a high IHC score were classified correctly.

Thus, our multicenter study showed that detection of SARS-CoV-2 proteins in human autopsy tissues is feasible yet is tainted with technical and interpretational difficulties, highlighting the importance of proper controls in autopsy studies and training of evaluators.

Guidance for identifying SARS-CoV-2 has been provided previously, however without detailed consideration of the specific challenges of autopsy tissues 20, 22, 23 . Key elements guiding ultrastructural identification of SARS-CoV-2 include the presence of a membrane envelope, surface projections (spikes), a granular interior (ribonucleoprotein), and diameters from 60 to 140 nm 20 . We searched for SARS-CoV-2 viral particles in the lung, olfactory mucosa (removed directly under the lamina cribrosa, but ultrastructurally only parts with ciliated and goblet cells were identifiable), medulla oblongata, kidney, trachea, and myocardium in autopsy tissues of 16 RT-qPCR-positive COVID-19 patients (Supplementary Table 6 ).

Overall, virus particles could be identified in 15 cells within the large-scale screening datasets of lung tissue of one patient. All virus-containing cells were found in two of the four digitized sections. Due to simplicity, we refer to these cells as infected cells, albeit intracellular virus particles in e.g. macrophages may be mainly composed of phagocytosed particles. Virus particles were well-preserved with distinct substructures ( Figure 4A ,B) and virus particles containing cells could be identified as type 2 pneumocytes and alveolar macrophages based on morphological criteria (Supplementary Table 7) .

Potential viral mimics such as swollen mitochondria, vesicles of rough endoplasmic reticulum (rER), and coated vesicles could be distinguished from viral particles (Supplementary Figure 6 perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 13, 2022. ; https://doi.org/10.1101/2022.01.13.22269205 doi: medRxiv preprint (possibly up to 40,000; cell 7) of CoV particles. Based on a rough approximation from viral RNA load, we can expect 0.006 (case 5) or 500 (case 1) CoV particles/ mm 2 ultrathin section area for low and high RNA load, respectively, which implies a huge difference in the likelihood of particle detection (see Virus particles could also be identified in several ciliated cells within olfactory mucosa of one patient (Supplementary Table 6 ; Figure 4C ,D). However, virus particles were less well-preserved due to the FFPE-embedding and paraffin extraction procedure prior to re-embedding for EM. Thus, their identification relied on comparison of more particles within each cell as well as presence of typical membrane compartments with multiple isomorphic particles enclosed. Virus particles appeared more condensed than virus particles after standard preparation for thin section EM with a mean diameter of 73 nm (± 7 nm; n=175; 58 to 108 nm; intracellular particles).

Of note, no virus particles were found in 26 samples of 14 patients in different tissues (Supplementary Table 6 ).

Based on reliable reference publications on ultrastructural in situ detection of CoV in human samples 21, 32, [35] [36] [37] [38] [39] , our previous work on SARS-CoV-2 in autopsy tissues 8, 18 , cell culture 16 , MERS 40 , and the results presented here, we developed refined criteria for identification of CoV particles in autopsy samples ( Table 2) .

We surveyed publications (published April 2020 to November 2021) using ultrastructural findings as proof of virus particles in human samples (Supplementary Tables 8,9 ) and re-evaluated the data using Table 10 ).

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 13, 2022. ; https://doi.org/10.1101/2022.01.13.22269205 doi: medRxiv preprint

One key question regarding severe to lethal COVID-19 is whether the clinical presentation including considerable organ damage is due to direct organ targeting of SARS-CoV-2 or downstream effects such as an overshooting immune response. During the COVID-19 pandemic, autopsy-driven research, using multimodal approaches, attempted at defining organ tropism of the virus and at unraveling organspecific pathomechanisms 8, 9, 25, [41] [42] [43] , yet a critical and systematic study investigating the limitations of in situ detection of SARS-CoV-2 in autopsy tissues has not been performed.

Looking into the discrepancy of results from studies using autopsy material to determine organ tropism and especially identification of organ-specific target cell types of SARS-CoV-2 for most organ systems Here we determined the limitations of SARS-CoV-2 detection by IHC and thin section EM using a defined set of control tissues including FFPE highly susceptible human cell lines and autopsy tissues with expectable high SARS-CoV-2 viral load. Finally, we performed a multicenter study assessing how well IHC performs in detecting SARS-CoV-2 proteins in autopsy tissues.

Assessment of a wide range of commercially available antibodies directed at SARS-CoV-2 proteins showed that only a subset of these can be reliably used in autopsy tissues (Supplementary Figure 3) .

Interestingly, antibodies against nucleocapsid protein showed highest sensitivity. This may be since, of all SARS-CoV-2 proteins, nucleocapsid protein is produced at the highest levels during the lifecycle of SARS-CoV-2 in cells 48 . Correspondingly, we found much less spike protein than nucleocapsid proteinbased on both, the amount per cell and the general abundance in affected tissues. This should be considered when interpreting studies proving multi-organ tropism and claiming specific target cell types for SARS-CoV-2, especially by using anti-spike antibodies 1,3,46,49,50 .

We found a discrepancy between viral RNA loads as determined by RT-qPCR and detection of SARS-CoV-2 proteins by immunohistochemistry. In fact, in tissues with low viral RNA loads immunohistochemistry is not a reliable method to determine organ tropism or target cell type as the interpretation of the rare immunosignals is difficult and nonspecific staining may be falsely interpreted as a positive signal. In agreement with this, we found low inter-observer reliability in tissues with low viral RNA loads (Supplementary Table 5 ). This may have to do with the fact that the distribution of the virus is uneven, even in highly affected organ systems such as lungs (Figure 3 ). The absence of viral proteins, on the other hand, cannot and should not be used as an argument for the absence of SARS-CoV-2-related tissue pathology, as autopsy tissues can only provide an incomplete snapshot of what has occurred in the sometimes very long clinical phase of the disease 51 . Recent studies have tried to address this point by studying autopsy tissues at different stages of COVID-19 44 . Our study also disclosed that it is crucial to choose suitable control tissues for immunohistochemistry not only based on high viral RNA loads but also on tissue integrity. Lung, for example, the tissue with the highest viral RNA loads cannot be considered an optimal control tissue as it tends to produce false-positive signals and difficult to interpret staining patterns. This may be because extensive tissue damage seen in COVID-All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 13, 2022. ; https://doi.org/10.1101/2022.01.13.22269205 doi: medRxiv preprint 19 lungs leads to pre-necrotic epithelial cells and hyaline membranes, both prone to false-positive signals. Also, this study shows that lungs often contain SARS-CoV-2 protein-harboring cell debris and mucus leading to difficulties to interpret signals ( Figure 3) . However, these limitations may also be valid for other (autopsy) tissues. Thus, it is warranted to carefully discriminate between direct SARS-CoV-2 virus presence or infection and inflammation-related tissue pathology, since the latter might considerably contribute to false-positive signals in IHC.

Using EM to detect intact SARS-CoV-2 particles in autopsy tissues comes along with specific challenges such as a relatively low sensitivity as compared to e.g. RT-qPCR, limitations in cell-type identification, and high inter-observer variability depending on EM expertise. We found virus particles only in a minor fraction of patient samples (with comparatively high viral RNA load), also, virus particles were spatially highly confined. In fact, individual cells may contain up to tens of thousands CoV particles and hundreds of thousands of RNA copies. Thus, even in samples with a high SARS-CoV-2 load, few infected cells (~20 or less per 10,000 cells), possibly also mobile cells, could make up a significant fraction of the total viral load. This result aligns with light microscopic findings suggesting a focal infection and argues for the complementarity of both methods so as not to misguide research 18, 21 . However, quantity of viral load may be cell type-specific and also depend on the disease phase. Moreover, presence of intracellular particles in e.g. macrophages may variably be a result of phagocytosis and not infection, thus indicating a need for further research on this correlation.

Based on our data, we provide recommendations on a suitable strategy for identifying virus-infected cells in Table 2 . We slightly expanded and detailed previously published criteria 20 All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted January 13, 2022. ; https://doi.org/10.1101/2022.01.13.22269205 doi: medRxiv preprint perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 13, 2022. ; https://doi.org/10.1101/2022.01.13.22269205 doi: medRxiv preprint perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 13, 2022. ; https://doi.org/10.1101/2022.01.13.22269205 doi: medRxiv preprint Of note, widespread detection (score+++) of nucleocapsid in lung tissue is only associated with high RNA loads/low ct values, whereas at high ct values (low RNA) detection of positive cells is comparatively low.

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 13, 2022. ; https://doi.org/10.1101/2022.01.13.22269205 doi: medRxiv preprint volumes (about 90 nm in diameter) captured within the section volume (about 60 nm thickness); a larger particle volume within the section results in higher electron density, a phenomenon that is typical for spherical particles with an electron dense interior (as compared to e.g. empty vesicles). (B) Very few particles demonstrate prominent (well-visible) surface projections, e.g. the right CoV particle (white arrowheads) as compared to the left CoV particle. The two particles show the heterogeneous nature of the RNP in such preparations, with distinct granular and some elongated profiles (black arrowheads) in the left particle and a more granular luminal matrix with few distinct profiles in the right particle. (C) Infected cells within the olfactory mucosa also show membrane compartments (black arrows) with All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 13, 2022. ; https://doi.org/10.1101/2022.01.13.22269205 doi: medRxiv preprint numerous coronavirus particles and also grouped extracellular particles that typically adhere to kinocilia and microvilli (white arrows), but individual particles are less well-preserved and more difficult to identify than particles in A and B. Virus particles appear as groups of electron dense particles of rather uniform size. (D) Virus particles at higher magnification (another region as shown in C). The particles are surrounded by a biomembrane (white arrow) which only rarely show surface projections (white arrowheads; note the globular shape of their peripheral part and also the relatively low electron density as compared to e.g. the RNP). The granular luminal matrix, formed by the RNP, is only visible in a few particles (black arrowhead). Individual images were acquired manually at high resolution by scanning transmission electron microscopy (STEM; A,B) and transmission electron microscopy (TEM; C,D).

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 13, 2022. ; https://doi.org/10.1101/2022.01.13.22269205 doi: medRxiv preprint corresponding to a large particle volume within the section and are relatively well preserved with a round to oval shape. Different representative appearances are shown here; small particle (D), a standardsized particle with evenly distributed granular-appearing RNP (E), partly elongated-appearing RNP (F), a larger particle with slightly irregular interior (G). (H-K) Less electron dense type 2 CoV particles, corresponding to a smaller particle volume within the section, while being also relatively well preserved; All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 13, 2022. ; https://doi.org/10.1101/2022.01.13.22269205 doi: medRxiv preprint relatively electron dense particle with well-recognizable biomembrane (H), less electron dense particles with also less distinct biomembrane (I-K). Note that the partly granular and partly elongated RNP profiles are still visible. (L-O) Type 3 CoV particles have the electron density of type 1 or type 2 CoV particles, but show more bizarre shapes. (P-S) Type 4 CoV particles were defined as all extracellular particles next to infected cells; well preserved dark particle (P), some particles showed prominent "fuzzy" coats (Q), less electron dense (R) and deformed (S) particles. (T) Visualization of different particle types in QuPath; type 1 (blue), type 2 (red) and type 3 (green).

See also www.nanotomy.org for internet browser-based open access pan-and-zoom analysis of the full resolution datasets and for our Supplementary Video demonstrating how large-scale electron microscopy facilitates ultrastructural analysis and visual pattern recognition.

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted January 13, 2022. ; Table 1 . Recommendations for detection of SARS-CoV-2 proteins by IHC in formalin-fixed paraffinembedded (FFPE) human autopsy tissues 1 Determination of virus load by RT-qPCR may give an overestimated picture of the tissue burden; SARS-CoV-2 positive cells might be comparatively rare.

2 IHC is not suited to detect low virus amounts in cells due to unfavourable signal to background ratio in human autopsy tissues; positive cells in tissues carry a rather high virus protein load (see Figures 1,3; Supplementary Figures 3,5) . Keep in mind that more (nonspecific) signal in tissues could be infection specific, but might not be a SARS-CoV-2 virus protein staining. It is highly recommended to employ a secondary antibody only control or isotype control in IHC. 9 We recommend to evaluate staining results on a microscope (possibility to focus in z-plane) and not on a scanned image to avoid misinterpretation of nonspecific staining artefacts on the tissue surface.

10 Some autopsy tissues provide exceptional high background staining such as kidney or placenta and should only be validated together with RT-qPCR results and comparable positive and negative tissues.

Nucleocapsid staining is planar and intracellular, but does not produce single punctuate dots.

Fluorescence microscopy is more prone to background signal than chromogenic IHC due to autofluorescence in human autopsy tissues. Check tissues in several channels to exclude autofluorescent "dots". 2 Size 50-180 nm (mean = 87 ± 13 nm; without spikes), with smaller particles in re-embedded FFPE material (mean = 73 ± 7 nm, 58-108 nm). In the range also described for cell culture 16, 68 and autopsy lung 20 .

3 Membrane At least partially visible around the particle.

projections Thin stalk and a globular component (in total about 20 nm long 16 ), at least the globular component needs to be discernible with some distance from the biomembrane. The electron density is considerably lower than surface structures of e.g. coated vesicles and the particle surface usually is not entirely covered 16 .

Note that the visibility of surface projections may be heterogeneous within the sample and also depends All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted January 13, 2022. ; https://doi.org/10.1101/2022.01.13.22269205 doi: medRxiv preprint on additives applied during tissue embedding such as en bloc treatment with tannic acid and uranyl acetate 16,32 . 5 Interior structure Inhomogeneous granular (never empty or homogeneous at low electron density), ribonucleoprotein (RNP) profiles are round/aggregated or oval/longitudinal structures. Based on our findings, the RNP profile diameter is generally between 3.6-13 nm (mean = 7.2 nm ± 1.6 nm), as published 20,23 .

Particles must be present at higher number and should often occur in groups within cells 8,21,35 . 7 Location Extracellular: individual particles or small groups, sometimes attaching to outer surface of membranes.

Intracellular: within small compartments with e.g. 1 particle up to very large compartments with dozens of particles, sometimes attaching to the inner surface of the membranes, but compartments with more than 1 particle should be identifiable as different structures such as swollen mitochondria may produce a "one-particle within a membrane compartment" appearance.

General considerations Prioritize analysis of few, carefully selected samples with a high viral load. Controls are not required for virus identification, because EM allows a direct (label-free) proof of the respective particles. 

Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series

Presumed SARS-CoV-2 Viral Particles in the Human Retina of Patients With COVID-19

COVID-19 targets human adrenal glands

Identification of SARS-CoV-2 inhibitors using lung and colonic organoids

SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Detection methods for SARS-CoV-2 in tissue

Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19

Multiorgan and Renal Tropism of SARS-CoV-2

Dysregulation of brain and choroid plexus cell types in severe COVID-19

Modern uses of electron microscopy for detection of viruses

Virus detection by transmission electron microscopy: Still useful for diagnosis and a plus for biosafety

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges

SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology

Morphometry of SARS-CoV and SARS-CoV-2 particles in ultrathin plastic sections of infected Vero cell cultures

Integrative Imaging Reveals SARS-CoV-2-Induced Reshaping of Subcellular Morphologies

Why misinterpretation of electron micrographs in SARS-CoV-2-infected tissue goes viral

Electron microscopy of SARS-CoV-2: a challenging task

Difficulties in Differentiating Coronaviruses from Subcellular Structures in Human Tissues by Electron Microscopy

Associated with Fatal Coronavirus Disease, United States

Best practices for correctly identifying coronavirus by transmission electron microscopy

Hunting coronavirus by transmission electron microscopy -a guide to SARS-CoV-2-associated ultrastructural pathology in COVID-19 tissues

Viral infiltration of pancreatic islets in patients with COVID-19

Neuropathology of patients with COVID-19 in Germany: a post-mortem case series

Publishing and sharing multi-dimensional image data with OMERO

Preparation of Samples for Large-Scale Automated Electron Microscopy of Tissue and Cell Ultrastructure

TrakEM2 software for neural circuit reconstruction

Open source software for digital pathology image analysis

Fiji: an open-source platform for biologicalimage analysis

Interrater reliability: the kappa statistic

Ultrastructural characterization of SARS coronavirus

To be or not to be? Examples of incorrect identification of autophagic compartments in conventional transmission electron microscopy of mammalian cells

Electron microscopy techniques employed to explore mitochondrial defects in the developing rat brain following ketamine treatment

Ultrastructure of human nasal epithelium during an episode of coronavirus infection

Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan

The spectrum of pathological changes in severe acute respiratory syndrome (SARS)

Severe acute respiratory syndrome (SARS)

A novel coronavirus associated with severe acute respiratory syndrome

Emerging human middle East respiratory syndrome coronavirus causes widespread infection and alveolar damage in human lungs

The SARS-CoV-2 main protease M(pro) causes microvascular brain pathology by cleaving NEMO in brain endothelial cells

SARS-CoV-2 in severe COVID-19 induces a TGF-beta-dominated chronic immune response that does not target itself

Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died

Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb

SARS-CoV-2 RNA screening in routine pathology specimens

Neuroinvasion of SARS-CoV-2 in human and mouse brain

Correlates of critical illness-related encephalopathy predominate postmortem COVID-19 neuropathology

Coronavirus biology and replication: implications for SARS-CoV-2

Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study

Prospective postmortem evaluation of 735 consecutive SARS-CoV-2-associated death cases

Current and future delivery of diagnostic electron microscopy in the UK: results of a national survey

Quality standards for diagnostic electron microscopy

Multiple organ infection and the pathogenesis of SARS

Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways

Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis

The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients

Neurological manifestations in COVID-19 caused by SARS-CoV-2

COVID-19: ICU delirium management during SARS-CoV-2 pandemic

Nervous system involvement after infection with COVID-19 and other coronaviruses

Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms

Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain

Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2

Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins

Large-scale electron microscopy database for human type 1 diabetes

A Complete Electron Microscopy Volume of the Brain of Adult Drosophila melanogaster

A Novel Coronavirus from Patients with Pneumonia in China